Bothell, WA, United States of America

Byron Hua Kwan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Byron Hua Kwan: Innovator in Cancer Treatment

Introduction

Byron Hua Kwan is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of cancer treatment through his innovative work on anti-PD-L1 antibodies and antibody-drug conjugates. His research aims to provide new methods for combating cancer, showcasing his dedication to advancing medical science.

Latest Patents

Kwan holds a patent for "Anti-PD-L1 antibodies and antibody-drug conjugates." This patent includes novel anti-PD-L1 antibodies and antibody-drug conjugates, along with methods for using these innovations to treat cancer. His work in this area is crucial for developing effective cancer therapies.

Career Highlights

Byron Kwan is currently employed at Seagen Inc., a company known for its focus on innovative cancer therapies. His role at Seagen allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Kwan has worked alongside talented colleagues, including Heather Van Epps and Andrew Waight. Their combined expertise enhances the research efforts at Seagen and fosters an environment of innovation.

Conclusion

Byron Hua Kwan is a prominent figure in the field of cancer treatment, with a focus on anti-PD-L1 antibodies and antibody-drug conjugates. His contributions are vital for the ongoing fight against cancer, and his work continues to inspire advancements in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…